Campagne de collecte 15 septembre 2024 – 1 octobre 2024 C'est quoi, la collecte de fonds?
1

Francis Bacon and Lionel Cranfield

Année:
1960
Langue:
english
Fichier:
PDF, 2.48 MB
english, 1960
3

PMD14 Vox Populi: Stated Preferences for Pharmaceutical Innovations

Année:
1998
Fichier:
PDF, 1.11 MB
1998
12

PMC28 STATUS-QUO BIAS IN STATED-CHOICE STUDIES: IS IT REAL?

Année:
2008
Langue:
english
Fichier:
PDF, 93 KB
english, 2008
13

PR3 BIPOLAR PATIENTS' STATED THERAPY PREFERENCES AND LIKELY ADHERENCE

Année:
2005
Langue:
english
Fichier:
PDF, 55 KB
english, 2005
16

PMC19 HOW GOOD IS GOOD ENOUGH? INTERNAL VALIDITY OF STATED PREFERENCES FOR DRUG THERAPIES

Année:
2007
Langue:
english
Fichier:
PDF, 67 KB
english, 2007
17

PDB56 PREFERENCES FOR ORAL ANTIDIABETIC AGENTS AMONG PEOPLE WITH TYPE 2 DIABETES

Année:
2008
Langue:
english
Fichier:
PDF, 67 KB
english, 2008
19

PMC29 PATIENT PREFERENCE WEIGHTS FOR BENEFIT-RISK ANALYSIS: A STATIN CASE STUDY

Année:
2010
Langue:
english
Fichier:
PDF, 68 KB
english, 2010
23

PR4 LINEAR SCORING RULES FOR PATIENT REPORTED OUTCOMES AND PATIENT PREFERENCES

Année:
2009
Langue:
english
Fichier:
PDF, 80 KB
english, 2009
25

PP4 LIVES WORTH LIVING: OLDER SMOKERS' STATED PREFERENCES FOR LONGEVITY

Année:
2009
Langue:
english
Fichier:
PDF, 90 KB
english, 2009
26

UT3 HEALTHY-DAYS TIME EQUIVALENTS FOR OUTCOMES OF ACUTE ROTAVIRUS INFECTIONS

Année:
2009
Langue:
english
Fichier:
PDF, 78 KB
english, 2009
27

PMC70 CLASSIFYING PATIENT REPORTED OUTCOMES: DEVELOPMENTS IN THE FIELD SUGGEST A NEW TAXONOMY

Année:
2009
Langue:
english
Fichier:
PDF, 75 KB
english, 2009
28

POR10: PREDICTING MARKET SHARES FOR NEW PHARMCEUTICAL PRODUCTS USING STATED PREFERENCES

Année:
1999
Langue:
english
Fichier:
PDF, 54 KB
english, 1999
34

PMI13 STANDARD GAMBLE AND CONJOINT UTILITY WEIGHTS: VALIDITY, FEASIBILITY, AND USEFULNESS

Année:
2002
Langue:
english
Fichier:
PDF, 60 KB
english, 2002
36

PDB22 THE VALUE TO HIGH-RISK PATIENTS OF PREVENTING A CASE OF DIABETES

Année:
2004
Langue:
english
Fichier:
PDF, 47 KB
english, 2004
37

QLI IS RELIEF WORTH THE RISK? RISK-BENEFIT PREFERENCES FOR TREATMENTS FORVASOMOTOR SYMPTOMS

Année:
2005
Langue:
english
Fichier:
PDF, 65 KB
english, 2005
38

PIH20 CONJOINT-ANALYSIS QALYS FOR ACUTE CONDITIONS

Année:
2006
Langue:
english
Fichier:
PDF, 70 KB
english, 2006
40

PDB27: RISKING HEALTH TO AVOIDING INJECTIONS—STATED PREFERENCES OF TYPE 2 DIABETICS IN THE US AND CANADA

Année:
2003
Langue:
english
Fichier:
PDF, 60 KB
english, 2003
42

PAR16 CAN OSTEOARTHRITIS PATIENTS EVALUATE TRADEOFFS BETWEEN NSAID RISKS AND BENEFITS?

Année:
2006
Langue:
english
Fichier:
PDF, 64 KB
english, 2006
48

PIN44 INCORPORATING PROBABILISTIC ATTRIBUTES IN A STATED-CHOICE RISK-BENEFIT SURVEY

Année:
2007
Langue:
english
Fichier:
PDF, 66 KB
english, 2007